Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FirstDiagnostics is a molecular diagnostics company specializing in the development of high-precision digital PCR (dPCR) systems and associated reagents. Headquartered in Suzhou, China, the company provides advanced platforms for absolute nucleic acid quantification, which are critical for liquid biopsy, oncology monitoring, and infectious disease detection. Their flagship Drop-Trace dPCR system offers high sensitivity and throughput, enabling the detection of rare genetic mutations and low-abundance biomarkers. FirstDiagnostics serves a diverse client base including clinical laboratories, research institutions, and pharmaceutical companies globally. The company is committed to advancing personalized medicine through innovative, automated diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FirstDiagnostics.